Coeshott C - Search Results

1

Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity.

Stubbs AC, Martin KS, Coeshott C, Skaates SV, Kuritzkes DR, Bellgrau D, Franzusoff A, Duke RC, Wilson CC. Stubbs AC, et al. Among authors: coeshott c. Nat Med. 2001 May;7(5):625-9. doi: 10.1038/87974. Nat Med. 2001. PMID: 11329066

2

A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.

King TH, Kemmler CB, Guo Z, Mann D, Lu Y, Coeshott C, Gehring AJ, Bertoletti A, Ho ZZ, Delaney W, Gaggar A, Subramanian GM, McHutchison JG, Shrivastava S, Lee YJ, Kottilil S, Bellgrau D, Rodell T, Apelian D. King TH, et al. Among authors: coeshott c. PLoS One. 2014 Jul 22;9(7):e101904. doi: 10.1371/journal.pone.0101904. eCollection 2014. PLoS One. 2014. PMID: 25051027 Free PMC article.

3

Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial.

Cohn A, Morse MA, O'Neil B, Whiting S, Coeshott C, Ferraro J, Bellgrau D, Apelian D, Rodell TC. Cohn A, et al. Among authors: coeshott c. J Immunother. 2018 Apr;41(3):141-150. doi: 10.1097/CJI.0000000000000219. J Immunother. 2018. PMID: 29528991 Free PMC article. Clinical Trial.

4

A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer.

Muscarella P, Bekaii-Saab T, McIntyre K, Rosemurgy A, Ross SB, Richards DA, Fisher WE, Flynn PJ, Mattson A, Coeshott C, Roder H, Roder J, Harrell FE, Cohn A, Rodell TC, Apelian D. Muscarella P, et al. Among authors: coeshott c. J Pancreat Cancer. 2021 Mar 23;7(1):8-19. doi: 10.1089/pancan.2020.0021. eCollection 2021. J Pancreat Cancer. 2021. PMID: 33786412 Free PMC article.

5

Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study.

Gaggar A, Coeshott C, Apelian D, Rodell T, Armstrong BR, Shen G, Subramanian GM, McHutchison JG. Gaggar A, et al. Among authors: coeshott c. Vaccine. 2014 Sep 3;32(39):4925-31. doi: 10.1016/j.vaccine.2014.07.027. Epub 2014 Jul 18. Vaccine. 2014. PMID: 25045824 Free article. Clinical Trial.

6

Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation.

Chaft JE, Litvak A, Arcila ME, Patel P, D'Angelo SP, Krug LM, Rusch V, Mattson A, Coeshott C, Park B, Apelian DM, Kris MG, Azzoli CG. Chaft JE, et al. Among authors: coeshott c. Clin Lung Cancer. 2014 Nov;15(6):405-10. doi: 10.1016/j.cllc.2014.06.002. Epub 2014 Jun 21. Clin Lung Cancer. 2014. PMID: 25044103 Clinical Trial.

7

Pluronic F127-based systemic vaccine delivery systems.

Coeshott CM, Smithson SL, Verderber E, Samaniego A, Blonder JM, Rosenthal GJ, Westerink MA. Coeshott CM, et al. Vaccine. 2004 Jun 23;22(19):2396-405. doi: 10.1016/j.vaccine.2003.11.064. Vaccine. 2004. PMID: 15193401

8

Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3.

Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H, Leimer AH, Cheronis J. Coeshott C, et al. Proc Natl Acad Sci U S A. 1999 May 25;96(11):6261-6. doi: 10.1073/pnas.96.11.6261. Proc Natl Acad Sci U S A. 1999. PMID: 10339575 Free PMC article.

9

ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid.

Westerink MA, Smithson SL, Srivastava N, Blonder J, Coeshott C, Rosenthal GJ. Westerink MA, et al. Among authors: coeshott c. Vaccine. 2001 Dec 12;20(5-6):711-23. doi: 10.1016/s0264-410x(01)00423-6. Vaccine. 2001. PMID: 11738734

10

Ultrasound-Guided Injections of HYADD4 for Knee Osteoarthritis Improves Pain and Functional Outcomes at 3, 6, and 12 Months without Changes in Measured Synovial Fluid, Serum Collagen Biomarkers, or Most Synovial Fluid Biomarker Proteins at 3 Months.

Meehan RT, Gill MT, Hoffman ED, Coeshott CM, Galvan MD, Wolf ML, Amigues IA, Kastsianok LM, Regan EA, Crooks JL, Czuczman GJ, Knight V. Meehan RT, et al. Among authors: coeshott cm. J Clin Med. 2023 Aug 25;12(17):5541. doi: 10.3390/jcm12175541. J Clin Med. 2023. PMID: 37685608 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page